Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Greidanus J, de Vries E, Mulder N. Steijfer D, Uges D, Oosterhuis B, Willemse P (1989) A phase I pharmacokinetic study of 21 day continuous infusion mitoxantrone. J Chir Oncol 7 (6): 790–797
2. Linkesch W, Thaler J, Gattringer C, Konwalinka G (1990) Continuous infusion of mitoxantrone combined with high-dose cytarabine in refractory/relapsed acute myeloblastic leukemia and blast crisis of chronic myelogenous leukemia. Haematol Blood Trans-fus 33: 330–332
3. Büchner T, Barlogie B, Asseburg U, Hiddemann W, Kamanbroo D, Göhde W (1974) Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside. Blut 28: 299
4. Edelstein M, Vietti T, Valeriote F (1974) Schedule dependent synergism for the combination of 1–13-D-arabinofuranosylcytosine and daunorubicin. Cancer Res 34: 293
5. Colly LP, van Bekkum DW, Hagenbeek A (1984) Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model ( BNML) for human acute myelocytic leukemia. Leuk Res 8: 953